Search research articles
Contact Us
Filters
Showing results (251-260 of 302) with videos related to
Page
of 31
Sort By:
British Journal of Cancer
|
April 13, 2013
Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype
M Lazzeroni, A Guerrieri-Gonzaga, E Botteri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 21, 2012
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement
S Guiu, S Michiels, F André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2019
Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy
J H Park, S F Jonas, G Bataillon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 2014
High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial
G Viale, L Slaets, J Bogaerts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 28, 2009
Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study
A Guerrieri-Gonzaga, E Botteri, M Lazzeroni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 20, 2008
Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup Phase III BIG 02-98 Trial
B C Pestalozzi, P Francis, E Quinaux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 12, 2020
Identifying oncogenic drivers associated with increased risk of late distant recurrence in postmenopausal, estrogen receptor-positive, HER2-negative early breast cancer: results from the BIG 1-98 study
S J Luen, R Asher, C K Lee, et al.
Breast Cancer Research and Treatment
|
April 1, 2011
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
G Cancello, P Maisonneuve, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 22, 2024
Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG Partners Foundation
S Peters, S Loi, F André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2015
Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial
E Munzone, A Giobbie-Hurder, B A Gusterson, et al.
Page
of 31
Search research articles
Search
Showing results (251-260 of 302) with videos related to
Sort By:
Page
of 31
British Journal of Cancer
|
April 13, 2013
Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype
M Lazzeroni, A Guerrieri-Gonzaga, E Botteri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 21, 2012
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement
S Guiu, S Michiels, F André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2019
Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy
J H Park, S F Jonas, G Bataillon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 2014
High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial
G Viale, L Slaets, J Bogaerts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 28, 2009
Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study
A Guerrieri-Gonzaga, E Botteri, M Lazzeroni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 20, 2008
Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup Phase III BIG 02-98 Trial
B C Pestalozzi, P Francis, E Quinaux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 12, 2020
Identifying oncogenic drivers associated with increased risk of late distant recurrence in postmenopausal, estrogen receptor-positive, HER2-negative early breast cancer: results from the BIG 1-98 study
S J Luen, R Asher, C K Lee, et al.
Breast Cancer Research and Treatment
|
April 1, 2011
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
G Cancello, P Maisonneuve, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 22, 2024
Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG Partners Foundation
S Peters, S Loi, F André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2015
Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial
E Munzone, A Giobbie-Hurder, B A Gusterson, et al.
Page
of 31